As he laced up his running shoes and donned a St. Jude Hero singlet before the 2016 St. Jude Memphis Marathon, James Eversull knew he was already victorious. Eversull’s race began in 1964, when he and his terrified parents passed through the doors of St. Jude Children’s Research Hospital. As a participant in the revolutionary “Total Therapy” regimen, Eversull was one of the first children to be cured of acute lymphoblastic leukemia. Now 53 years old, he supports the hospital through participation in the St. Jude LIFE long-term follow-up study as well as through running marathons and speaking on behalf of St. Jude.
From Promise, Winter 2017
More articles from this issue
-
The Best Day Possible
The St. Jude Quality of Life for All team goes above and beyond to improve patients’ psychosocial, emotional, and symptom concerns.
-
Handwriting: Back to Basics
St. Jude staff members help children learn, or re-learn, the art of handwriting.
-
Young Readers are STARRs
The STARR program provides academic assistance for children with sickle cell disease and hemophilia.
-
Patients Pay it Forward
St. Jude Child Life unites five patients and inspires them to help one another persevere.
-
The 2017 Prom Challenge
Teenagers unite to party with a purpose.
-
Land of Opportunity
A gift of property supports the hospital’s Genomes for Kids clinical trial.
-
Snip of DNA Spells Hope
St. Jude scientists use gene editing in quest to help children with sickle cell disease.
-
Protection from Infection
There’s ‘clean,’ and then there’s ‘ St. Jude clean.’ Learn some of the tactics St. Jude uses to keep infection rates low.
-
Sabrina Soto Answers the Question, 'What's Really Important?'
Lifestyle expert Sabrina Soto explains how a focus on family makes St. Jude extra special.
-
Research Highlights - Promise Winter 2017
Find out about research discoveries and achievements in areas of precision medicine, genetics and genomics, mobile health, and patient safety.